Investment Firm
Overview
Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.
Jan 02, 2018
Series Unknown
Highlights
Location
Social
Participant Investors
1
Investor Name |
---|
Mercia Asset Management |
Medherant raised $3398586 on 2018-01-02 in Venture Round
Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Oct 03, 2018 | Grant - Medherant | 1 | - | 67.3K |
May 21, 2019 | Series A - Medherant | 1 | - | 2.2M |
Apr 03, 2023 | Venture Round - Medherant | 1 | - | 3.6M |
Sep 26, 2016 | Seed Round - Medherant | 1 | - | 1.9M |
Recent Activity
There is no recent news or activity for this profile.